Target intelligence / Profile preview

Host translation initiation factor eIF4G binding to Sabin 2 poliovirus IRES domain V (eIF4G-Sabin 2 IRES dV interaction)

Target
eIF4G-Sabin 2 IRES dV interaction
Molecular classification
Protein-RNA complex, Translation initiation factor, Viral IRES-host factor interaction
01

Overview

The interaction between the host eukaryotic initiation factor 4G (eIF4G) and domain V of the poliovirus internal ribosome entry site (IRES) is a fundamental requirement for the initiation of viral protein synthesis. In the Sabin 2 vaccine strain, a specific G-to-A point mutation at nucleotide 481 (G481A) within domain V significantly reduces the binding affinity of eIF4G, which is the primary mechanism for the strain's attenuated neurovirulence (Ochs et al., 2003; JBC, 2018). This interaction is essential for recruiting the 40S ribosomal subunit to the viral RNA, bypassing the need for a 5' cap (Sweeney et al., 2014). Because this interface is critical for viral replication but distinct from the mechanisms used for most host cell mRNAs, it represents a potential target for the development of specific antiviral agents. Small molecules like 4EGI-1 and hippuristanol have been used in research to study and inhibit this translational pathway, highlighting the therapeutic potential of disrupting the eIF4G-IRES complex (Cell, 2006; JBC, 2018).

Other names
eIF4G-PV IRES domain V interactioneIF4G-Sabin 2 IRES interactioneIF4G-Sabin 2 IRES dV complexeIF4G-Sabin 2 IRES domain V bindingeIF4G-PV2 IRES domain V binding
02

Mechanism of action

Inhibition of viral translation initiation by disrupting the recruitment of the 40S ribosomal subunit to the viral IRES.

03

Biological functions

Translation initiationViral replicationCap-independent translationNeurovirulence determination
04

Disease associations

PoliomyelitisInfection
05

Safety considerations

Potential for off-target inhibition of host cap-dependent translationGenetic instability of the Sabin 2 strain (reversion to neurovirulence)
06

Interacting drugs

4EGI-1

3 more in the full profile.

07

Biomarkers

Viral RNA levelseIF4G cleavage productsNeurovirulence markers

Beyond the preview

Go deeper on Host translation initiation factor eIF4G binding to Sabin 2 poliovirus IRES domain V (eIF4G-Sabin 2 IRES dV interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host translation initiation factor eIF4G binding to Sabin 2 poliovirus IRES domain V (eIF4G-Sabin 2 IRES dV interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call